SELLAS Life Sciences Group, Inc. Common Stock, Capital Shares Reserved for Future Issuance
SELLAS Life Sciences Group, Inc. (SLS) had Common Stock, Capital Shares Reserved for Future Issuance of 35.35 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-11
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 35.35M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 35.94M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 64.16M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 70.18M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 35.35M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 35.94M shares 10-Q · filed 2026-05-12 |
| 2025-12-31 | 64.16M shares 10-K · filed 2026-03-19 |
| 2025-09-30 | 70.18M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 75.54M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 84.21M shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 61.76M shares 10-K · filed 2025-03-20 |
| 2024-09-30 | 71.41M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 46.34M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 47.83M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 21.93M shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 18.39M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 18.57M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 15.57M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 7.35M shares 10-K · filed 2023-03-16 |
| 2022-09-30 | 7.40M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 7.41M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 2.80M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 2.01M shares 10-K · filed 2022-03-31 |
| 2021-09-30 | 2.06M shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 2.06M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 1.76M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 1.88M shares 10-K · filed 2021-03-23 |
| 2020-09-30 | 4.35M shares 10-Q · filed 2020-11-13 |
| 2020-06-30 | 1.61M shares 10-Q · filed 2020-08-13 |
| 2020-03-31 | 1.61M shares 10-Q · filed 2020-05-14 |
| 2019-12-31 | 532.00K shares 10-K · filed 2020-03-13 |
| 2019-09-30 | 531.00K shares 10-Q · filed 2019-11-14 |
| 2019-06-30 | 144.71M shares 10-Q · filed 2019-08-14 |
| 2019-03-31 | 19.67M shares 10-Q · filed 2019-05-15 |
| 2018-12-31 | 18.64M shares 10-K · filed 2019-03-22 |
| 2018-09-30 | 20.17M shares 10-Q · filed 2018-11-14 |
| 2018-06-30 | 4.10M shares 10-Q · filed 2018-08-14 |
| 2018-03-31 | 3.23M shares 10-Q · filed 2018-05-15 |
| 2017-12-31 | 1.62M shares 10-K · filed 2018-04-13 |
| 2017-09-30 | 20.47M shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 20.55M shares 10-Q · filed 2017-08-14 |
| 2017-03-31 | 20.63M shares 10-Q · filed 2017-05-10 |
| 2016-09-30 | 73.04M shares 10-Q · filed 2016-11-09 |
| 2016-06-30 | 59.11M shares 10-Q · filed 2016-08-09 |
| 2016-03-31 | 57.64M shares 10-Q · filed 2016-05-10 |
| 2015-09-30 | 44.27M shares 10-Q · filed 2015-11-09 |
| 2015-06-30 | 44.46M shares 10-Q · filed 2015-08-06 |
| 2015-03-31 | 34.70M shares 10-Q · filed 2015-05-07 |
| 2014-09-30 | 20.66M shares 10-Q · filed 2014-11-05 |
| 2014-06-30 | 21.93M shares 10-Q · filed 2014-08-11 |
| 2014-03-31 | 22.04M shares 10-Q · filed 2014-05-06 |
| 2013-09-30 | 34.89M shares 10-Q/A · filed 2013-11-07 |
| 2013-06-30 | 28.45M shares 10-Q · filed 2013-08-09 |
| 2013-03-31 | 25.29M shares 10-Q · filed 2013-05-09 |
| 2012-06-30 | 17.52M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |